Summary Text

SUMMARY: First diagnosed with myeloma October 2011. Recruited onto clinical trial Myeloma X11 (Lenalidomide) at Bristol Oncology and Haematology Centre. First High Dose Therapy and Stem Cell Transplant (HDT&SCT) in July 2012. On maintenance until June 2017. June 2018 recruited onto Myeloma XII trial (Ixazomib). December 2018 Second HDT&SCT. On maintenance until February 2020. August 2020 Commenced treatment involving Daratumumab. April 2021 relapsed. June 2021 recruited onto Cartitude 4 clinical trial and infused with CAR-T cells in October 2021. My own immune system is now fighting the cancer . I am exceedingly fortunate.


Saturday, 21 February 2015

A Dilemma

I attended clinic this week and, again, all was good news. My paraprotein remains undetectable and my consultant continues to be very happy with my progress.

You may recall that I was discharged from the ward after High Dose Therapy and Stem Cell Transplant in July 2012. It was not until two years later that my paraprotein had finally become undetectable. I've now just been prescribed maintenance cycle number 31. I continue to feel really well.

You may also recall that I have previously commented that we rarely recognise our good health, only noting when we feel unwell. This brings me to another such thought:  Only exceptionally do we consider our life expectancy. I don’t recall ever considering the potential to be “run over by a bus”. The more responsible amongst us perhaps ensure that we have a Will but that is as far as such thoughts typically go.

Discussion about cancer, of course, often includes a prediction of life expectancy – a prognosis. Probably in common with other myeloma patients I reacted to my prognosis by initially thinking very short term. As my treatment has progressed, and for the most part subconsciously, I have begun to think longer term. It is worth mentioning that, having received an initial prognosis from my consultant at the time, I also sought predictions from the internet. Dangerous. Some of the information I found was out of date and inaccurate. Even that published by Macmillan referred to data which itself was out of date. Cancer research has recently published survival data but even that requires some interpretation. Nobody can blame cancer patients from trying to understand their condition though.

My dilemma (and one that I wholeheartedly welcome) is, given my current remission, how far ahead should I plan? To what extent should I invest in my future? Having been appointed to be a JP is just one sign that I have planned for a future. Another is pursuing my passion for flying. I’m aware of some myeloma patients who suffer badly. Others, though, have already survived and enjoyed an extended life. I’m glad to have this dilemma! 
If you love life, don't waste time,
for time is what life is made up of.
Bruce Lee

You will note that I have routinely ended my posts with the expression KBO. Well I've found a new one which those who text will probably be aware of. So....

Keep well and YOLO

Stephen